Physician profile
Ryan K Norris
NPI 1265698716
$2,523.11
in general payments reported to CMS, 2019-2025
24 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $163 · 2021: $55.25 · 2022: $828 · 2023: $566 · 2024: $310 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $677.69 | 2019-2025 | Lifevest |
| Abbott Laboratories | $308.00 | 2019-2025 | Cardiomems, Mitraclip |
| Novartis Pharmaceuticals Corporation | $172.21 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $163.03 | 2019-2024 | Evkeeza |
| Amarin Pharma, INC. | $136.09 | 2019-2022 | |
| Pfizer INC. | $132.96 | 2019-2023 | |
| Heartflow, INC. | $118.98 | 2019 | |
| Merck Sharp & Dohme LLC | $96.51 | 2022-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $84.18 | 2019-2022 | |
| Boston Scientific Corporation | $83.50 | 2023 | Rotapro, Wolverine Coronary Cutting Balloon |
| Kestra Medical Technology Services, INC. | $80.22 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $71.43 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $64.61 | 2023 | |
| Irhythm Technologies, INC. | $58.83 | 2019-2022 | |
| Atricure, INC. | $44.30 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $40.96 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $40.75 | 2022 | |
| Amgen INC. | $31.28 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $25.81 | 2019-2020 | |
| Cvrx, INC. | $25.04 | 2025 | Barostim Neo System |
| Scpharmaceuticals INC. | $24.53 | 2024 | |
| Esperion Therapeutics, INC. | $19.43 | 2023 | Nexletol |
| Impulse Dynamics (USA) INC. | $15.39 | 2022 | |
| Surmodics, INC. | $7.38 | 2023 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.